The regulations have influenced the growth and sophistication of combination products as we have seen in the form of insulin pumps to manage diabetes (Figure 1), drug-coated dressings for improved wound healing, and more recently drug-vaccine inhalers and wearable drug delivery devices. The gene discussed is INS; the disease is diabetes mellitus.